Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
Brian P. McDonough, MD, FAAFP
Marie Wood, MD
Advancing Noninvasive CRC Screening: Exploring an Aptamer-Based Assay
Ryan Quigley
Hallie Blevins, PhD.
Marlene Mimi Maeusli, PhD.
Differentiating Large Cell Neuroendocrine Carcinoma from Other Lung Cancers
Balazs Halmos, MD, MS
Large Cell Neuroendocrine Carcinoma Care: A Look at Evolving Approaches
Using FTIR to Support Accurate Tissue Assessment in Colorectal Surgery
Ashley Baker, MSN, PMHNP
Heather Allen, PhD
Ran Li, PhD
Diagnosing LCNEC of the Lung: Challenges and Strategies
Junaid Arshad, MD, MS
SCNEC Diagnosis: Cytological Clues to a Rare Cervical Malignancy
Personalizing Care for Large Cell Neuroendocrine Carcinoma
DLL3 Expression in GEP-NECs: A Marker of Poor Differentiation and Emerging Therapeutic Target
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Fernando López-Ríos, MD, PhD
Christian Rolfo, MD, PhD
Charlie Gourley, MD, PhD
Guideline-recommended second-line treatment following an immune checkpoint inhibitor in renal cell carcinoma
Ignacio Duran, MD
Wenxin Xu, MD
Emerging immunotherapy combination strategies in genitourinary malignancies
Sandy Srinivas, MD
Emerging targeted therapy combination strategies in genitourinary malignancies
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.